Carole Tarpin
- Oncology top 2%
- Molecular Biology top 10%
- Cancer Research top 2%
- Pulmonary and Respiratory Medicine top 10%
- Genetics
- Co-authors
- Patrice ViensFrançois BertucciEmmanuelle Charafe‐JauffretDaniel BirnbaumJocelyne JacquemierGilles HouvenaeghelLuc XerriChristophe Ginestier
- Topics
- Breast Cancer Treatment Studies (18 papers)HER2/EGFR in Cancer Research (16 papers)Cancer Treatment and Pharmacology (14 papers)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
Carole Tarpin
49 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Oncology 1.1k
- Molecular Biology 857
- Cancer Research 723
- Pulmonary and Respiratory Medicine 275
- Genetics 166
Countries citing papers authored by Carole Tarpin
This map shows the geographic impact of Carole Tarpin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carole Tarpin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carole Tarpin more than expected).
Fields of papers citing papers by Carole Tarpin
This network shows the impact of papers produced by Carole Tarpin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carole Tarpin. The network helps show where Carole Tarpin may publish in the future.
Co-authorship network of co-authors of Carole Tarpin
This figure shows the co-authorship network connecting the top 25 collaborators of Carole Tarpin. A scholar is included among the top collaborators of Carole Tarpin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carole Tarpin. Carole Tarpin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 14 | |
| 3 | 2 | |
| 4 | 4 | |
| 5 | 6 | |
| 6 | 6 | |
| 7 | 16 | |
| 8 | 20 | |
| 9 | 80 | |
| 10 | Capecitabine after anthracycline and taxane exposure in HER2-negative metastatic breast cancer patients: response, survival and prognostic factors. | 15 |
| 11 | 26 | |
| 12 | 13 | |
| 13 | 15 | |
| 14 | 21 | |
| 15 | Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancerbreakdown → | 575 |
| 16 | 6 | |
| 17 | 1 | |
| 18 | 24 | |
| 19 | High-dose alkylating agents with autologous hematopoietic stem cell support and trastuzumab in ERBB2 overexpressing metastatic breast cancer: a feasibility study. | 10 |
| 20 | 2 |
About Carole Tarpin
Carole Tarpin is a scholar working on Cancer Research, Oncology and Family Practice, having authored 51 papers that have together received 2.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (18 papers), HER2/EGFR in Cancer Research (16 papers) and Cancer Treatment and Pharmacology (14 papers). The work is most often cited by research in Cancer Research (723 citations), Family Practice (91 citations) and Oncology (1.1k citations). Carole Tarpin has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Patrice Viens, François Bertucci, Emmanuelle Charafe‐Jauffret, Daniel Birnbaum, Jocelyne Jacquemier, Gilles Houvenaeghel, Luc Xerri, Christophe Ginestier, Benjamin Esterni and Pascal Finetti. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.